Although several indicators have been identified to monitor the progression of PCa, including prostate specific antigen (PSA), Gleason score, and lymph node invasion status, the ability to monitor the progression of cancer with good specificity and accuracy is still limited 3, 4. This evidence concerns the gene KLK3 and cancer.